BMC Cancer

official impact factor 3.15

Open Access Highly Access Research article

Genetic analysis of the vitamin D receptor gene in two epithelial cancers: melanoma and breast cancer case-control studies

Eva Barroso1, Lara P Fernandez1, Roger L Milne2, Guillermo Pita3, Elena Sendagorta4, Uxua Floristan4, Marta Feito4, Jose A Aviles5, Manuel Martin-Gonzalez6, Jose I Arias7, Pilar Zamora7, Monserrat Blanco8, Pablo Lazaro5, Javier Benitez3,1 and Gloria Ribas1*

  • * Corresponding author: Gloria Ribas gribas@cnio.es

  • † Equal contributors

Author Affiliations

1 Human Genetics Group; Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

2 Genetic and Molecular Epidemiology Group; Human Cancer Genetics Program, CNIO, Madrid, Spain

3 National Genotyping Centre (CeGen), Human Cancer Genetics Program, CNIO, Madrid, Spain

4 Department of Dermatology, La Paz Hospital, Madrid, Spain

5 Department of Dermatology, Gregorio MaraƱon Hospital, Madrid, Spain

6 Department of Dermatology, Ramon y Cajal Hospital, Madrid, Spain

7 Service of Surgery, Monte Naranco, Oviedo, Spain

8 Department of Oncology, La Paz Hospital, Madrid, Spain

For all author emails, please log on.

BMC Cancer 2008, 8:385 doi:10.1186/1471-2407-8-385

Published: 23 December 2008

Abstract

Background

Vitamin D serum levels have been found to be related to sun exposure and diet, together with cell differentiation, growth control and consequently, cancer risk. Vitamin D receptor (VDR) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma (MM) have been performed in a southern European population. In this study, the VDR gene has been evaluated in two epithelial cancers BC and MM.

Methods

We have conducted an analysis in 549 consecutive and non-related sporadic BC cases and 556 controls, all from the Spanish population, and 283 MM cases and 245 controls. Genotyping analyses were carried out on four putatively functional SNPs within the VDR gene.

Results

An association with the minor allele A of the non-synonymous SNP rs2228570 (rs10735810, FokI, Met1Thr) was observed for BC, with an estimated odds ratio (OR) of 1.26 (95% CI = 1.02–1.57; p = 0.036). The synonymous variant rs731236 (TaqI) appeared to be associated with protection from BC (OR = 0.80, 95%CI = 0.64–0.99; p = 0.047). No statistically significant associations with MM were observed for any SNP. Nevertheless, sub-group analyses revealed an association between rs2228570 (FokI) and absence of childhood sunburns (OR = 0.65, p = 0.003), between the 3'utr SNP rs739837 (BglI) and fair skin (OR = 1.31, p = 0.048), and between the promoter SNP rs4516035 and the more aggressive tumour location in head-neck and trunk (OR = 1.54, p = 0.020).

Conclusion

In summary, we observed associations between SNPs in the VDR gene and BC risk, and a comprehensive analysis using clinical and tumour characteristics as outcome variables has revealed potential associations with MM. These associations required confirmation in independent studies.